Acquired Point Mutations of TKD Are Responsible for Sorafenib Resistance in FLT3-ITD Mutant AML

被引：0
|
作者：
Zhang, Weiguo [1 ]
Konopleva, Marina [1 ]
Jacamo, Rodrigo O. [1 ]
Borthakur, Gautam
Chen, Wenjing
Cortes, Jorge E.
Ravandi, Farhad
Andreeff, Michael [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
LEUKEMIA;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1495 / 1495
页数：1
相关论文
共 50 条
  • [1] FLT3-ITD but not FLT3-TKD mutations have major prognostic impact in normal karyotype AML
    Schneider, Stephanie
    Schneider, Friederike
    Dufour, Annika
    Mellert, Gudrun
    Zellmeier, Evelyn
    Braess, Jan
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Fritsch, Susanne
    Heinecke, Achim
    Sauerland, Maria C.
    Hoster, Eva
    Unterhalt, Michael
    Berdel, Wolfgang E.
    Wormann, Bernhard J.
    Buechner, Thomas
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BLOOD, 2007, 110 (11) : 1021A - 1021A
  • [2] Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations
    Scholl, Sebastian
    Spies-Weisshart, Baerbel
    Klink, Anne
    Muegge, Lars-Olof
    Fricke, Hans-Joerg
    Hochhaus, Andreas
    ANNALS OF HEMATOLOGY, 2011, 90 (04) : 473 - 475
  • [3] Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations
    Sebastian Scholl
    Baerbel Spies-Weisshart
    Anne Klink
    Lars-Olof Muegge
    Hans-Joerg Fricke
    Andreas Hochhaus
    Annals of Hematology, 2011, 90 : 473 - 475
  • [4] Acquired Isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations
    M Griffiths
    J Mason
    M Rindl
    S Akiki
    D McMullan
    V Stinton
    H Powell
    A Curtis
    N Bown
    C Craddock
    Leukemia, 2005, 19 : 2355 - 2358
  • [5] Acquired isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations
    Griffiths, M
    Mason, J
    Rindl, M
    Akiki, S
    McMullan, D
    Stinton, V
    Powell, H
    Curtis, A
    Bown, N
    Craddock, C
    LEUKEMIA, 2005, 19 (12) : 2355 - 2358
  • [6] Acquired uniparental disomy for chromosome 13 is associated with FLT3-itd mutations in AML
    Akiki, S
    Stinton, V
    Rindl, M
    Mason, J
    Bryon, J
    Ely, A
    Griffiths, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 29 - 30
  • [7] Acquired isodisomy for chromosome 13 is common and associated with FLT3-itd mutations in AML
    Griffiths, M
    Mason, J
    McMullan, D
    Akiki, S
    Rindl, M
    Powell, H
    Curtis, A
    Bown, N
    JOURNAL OF MEDICAL GENETICS, 2005, 42 : S83 - S83
  • [8] FLT3-ITD activation mediates resistance to the BCL-2 selective antagonist, venetoclax, in FLT3-ITD mutant AML models
    Mali, Raghuveer
    Lasater, Elisabeth A.
    Doyle, Kelly
    Malla, Ritu
    Boghaert, Erwin
    Souers, Andrew
    Leverson, Joel
    Sampath, Deepak
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [9] FLT3-ITD Activation Mediates Resistance to the BCL-2 Selective Antagonist, Venetoclax, in FLT3-ITD Mutant AML Models
    Mali, Raghuveer Singh
    Lasater, Elisabeth A.
    Doyle, Kelly
    Malla, Ritu
    Boghaert, Erwin
    Souers, Andrew
    Leverson, Joel D.
    Sampath, Deepak
    BLOOD, 2017, 130
  • [10] Combined Targeting of BcI-2 and XPO1 Overcomes Acquired Resistance to Tyrosine Kinase Inhibitors in the FLT3-ITD/TKD Double Mutant AML
    Tabe, Yoko
    Yamatani, Kotoko
    Yang, Haeun
    Saito, Kaori
    Murakami-Tonami, Yuko
    Suzuki, Koya
    Zhang, Weiguo
    Kinjo, Sonoko
    Ikeo, Kazuho
    Hosoya, Masaki
    Mogushi, Kaoru
    Yamaguchi, Shigeo
    Harada, Hironori
    Miida, Takashi
    Shah, Neil
    Konopleva, Marina Y.
    Hayashizaki, Yoshihide
    Andreeff, Michael
    BLOOD, 2018, 132
12345